Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/1997
07/23/1997EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus
07/23/1997EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase
07/23/1997EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785256A1 Staphylococcus aureus glycyl-tRNA synthetase
07/23/1997EP0785201A1 Heterodatom containing cyclopentanopyridyl-Oxazolidinones
07/23/1997EP0785200A2 Pyridoannelated thienyl and furamyl-oxazolidinones
07/23/1997EP0785197A2 2-oxo and 2-thio-1,2-dihydroquinolinyl-oxazolidinones
07/23/1997EP0784688A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
07/23/1997EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
07/23/1997EP0784683A1 Tie-2 ligands, methods of making and uses thereof
07/23/1997EP0784677A1 Inhibitor of stem cell proliferation and uses thereof
07/23/1997EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
07/23/1997EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
07/23/1997EP0784624A1 Purine and guanine compounds as inhibitors of pnp
07/23/1997EP0784485A1 Vaccine compositions
07/23/1997EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
07/23/1997EP0784472A1 Agent for treating papilloma virus-positive malignant and premalignant lesions
07/23/1997EP0784470A1 Liposome-formulations for treatment of viral diseases
07/23/1997EP0784466A1 Use and composition of an anti-sexually transmitted diseases formulation
07/23/1997EP0784430A1 Method for reducing unwanted cellular adhesions
07/23/1997EP0554400B1 Retroviral protease inhibitors
07/23/1997EP0532530B1 Derivatives of 6-aminooctahydroindolizinetriol
07/23/1997EP0531341B1 Use of leukoregulin for the treatment of animals infected with an envelope-virus
07/23/1997CN1155284A Thipyridines for use in control of helicobacter bacteria
07/22/1997US5650488 Polypeptide inhibitor of the replication of HSV
07/22/1997US5650432 Proanthocyanidins
07/22/1997US5650419 Thiadiazoles and their use as antipicornaviral agents
07/22/1997US5650417 Substituted pyridines, their preparation, and their use as pesticides and fungicides
07/22/1997US5650413 Enzyme inhibitors and antitumor agents
07/22/1997US5650411 Substituted azolone derivatives
07/22/1997US5650296 Expression of hepatitis B S and preS2 proteins in Pichia pastoris
07/22/1997US5650280 Cellubrevin homolog
07/22/1997US5650145 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith
07/19/1997CA2195177A1 Heteroatom-containing cyclopentanopyridyl-oxazolidinones
07/17/1997WO1997025425A1 Wsx receptor and ligands
07/17/1997WO1997025404A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997WO1997025352A1 PROCESS FOR ISOLATING IgG AND IgA
07/17/1997WO1997025342A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione
07/17/1997WO1997025337A1 Therapeutic compounds
07/17/1997WO1997025316A1 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
07/17/1997WO1997025309A1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
07/17/1997WO1997025106A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997WO1997025071A2 Immunoconjugate for the treatment of aids
07/17/1997WO1997025064A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
07/17/1997WO1997025055A1 Nisin in combination with glycerol monolaurate active against helicobacter
07/17/1997WO1997025046A1 Novel substituted imidazole compounds
07/17/1997WO1997025045A1 Novel substituted imidazole compounds
07/17/1997WO1997012042A3 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses
07/17/1997WO1997009429A3 Compounds and methods for diagnosis of tuberculosis
07/17/1997WO1997009428A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/17/1997CA2242778A1 Process for isolating igg and iga
07/17/1997CA2242514A1 Immunoconjugate for the treatment of aids
07/17/1997CA2242411A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997CA2242391A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997CA2242327A1 Novel substituted imidazole compounds
07/17/1997CA2241993A1 Therapeutic compounds
07/17/1997CA2241893A1 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
07/17/1997CA2241564A1 Wsx receptor and ligands
07/17/1997CA2240467A1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
07/17/1997CA2194945A1 2-oxo- and 2-thio-1,2- dihydroquinolinyl-oxazolidinones
07/17/1997CA2194938A1 Pyrido-fused thienyl- and furanyl-oxazolidinones
07/16/1997EP0783890A1 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine for the treatment of fungal dermatitis
07/16/1997EP0783525A1 Human-murine chimeric antibodies against respiratory syncytial virus
07/16/1997EP0783520A1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
07/16/1997EP0783518A1 Inhibitors of farnesyl-protein transferase
07/16/1997EP0783510A1 Human potassium channel 1 and 2 proteins
07/16/1997EP0783507A1 Compounds useful as antiproliferative agents and garft inhibitors
07/16/1997EP0783502A1 New carboxamides with antifungal activity
07/16/1997EP0783501A1 New pyrimidone derivatives with antifungal activity
07/16/1997EP0783474A1 Compounds for the suppression of hiv tat transactivation
07/16/1997EP0783321A1 Vr-2332 viral nucleotide sequence and methods of use
07/16/1997EP0783319A1 Muramyl peptide compositions for inhibiting hiv replication
07/16/1997EP0750620A4 Carbapenem compounds, compositions and methods of treatment
07/16/1997EP0674645B1 Cephem compounds with antimicrobial activity
07/16/1997EP0653936B1 Use of 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone for the treatment of cancer
07/16/1997EP0601154B1 Bpc peptides, their preparation and use
07/16/1997EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures
07/16/1997CN1154705A Organic compound
07/16/1997CN1154655A Method of purifying necrotoxin produced by bordetella and Toxoid
07/15/1997US5648493 Preparation of 7-(3-amino- and 3-amino-methyl-1-pyrrolidinyl)-3-quinolonecarboxylic acids and -naphthyridonecarboxylic acids
07/15/1997US5648467 Human cytokine
07/15/1997US5648459 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
07/15/1997US5648456 Reductive cleavage with borohydride
07/15/1997US5648455 Treatment of drug resistant bacteria
07/15/1997US5648381 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof
07/15/1997US5648379 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
07/15/1997US5648372 Antifungal agents, and compositions
07/15/1997US5648364 Heterocyclic peptide compounds as enzyme inhibitors
07/15/1997US5648361 Rapamycin derivatives
07/15/1997US5648358 Caffeine and pyrrolidine or piperidine ether antihistamine
07/15/1997US5648346 Antimicrobial carbacephem-quinolones
07/15/1997US5648341 Method of treating pulmonary inflammation by continuous administration of an adenosine-containing solution
07/15/1997US5648241 Conjugate vaccine against group B streptococcus
07/15/1997US5648234 Biosynthesis
07/15/1997US5648081 Actinobacillus pleuropneumoniae subunit vaccine
07/15/1997US5648080 Antigenic preparations and isolation of such preparations
07/15/1997US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor